OPPM

Opus Point Partners Management Portfolio holdings

AUM $46.9M
This Quarter Return
+8.8%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
AUM
$95M
AUM Growth
+$95M
Cap. Flow
-$5.81M
Cap. Flow %
-6.11%
Top 10 Hldgs %
53.5%
Holding
63
New
2
Increased
1
Reduced
29
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
LOXO
26
DELISTED
Loxo Oncology, Inc
LOXO
$1.16M 1.01% 13,800
ALXN
27
DELISTED
Alexion Pharmaceuticals Inc
ALXN
$1.14M 0.99% 9,558 -1,889 -17% -$226K
PCRX icon
28
Pacira BioSciences
PCRX
$1.2B
$1.14M 0.99% 25,000
CLVS
29
DELISTED
Clovis Oncology, Inc.
CLVS
$1.02M 0.88% 15,000
ADMS
30
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
$1.02M 0.88% 30,000
PRQR icon
31
ProQR Therapeutics
PRQR
$237M
$992K 0.86% +307,692 New +$992K
KPTI icon
32
Karyopharm Therapeutics
KPTI
$61.7M
$960K 0.83% 100,000
AXSM icon
33
Axsome Therapeutics
AXSM
$6.05B
$748K 0.65% 133,500
PRTK
34
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$716K 0.62% 40,000
CKPT
35
DELISTED
Checkpoint Therapeutics
CKPT
$438K 0.38% 112,760
TSRO
36
DELISTED
TESARO, Inc.
TSRO
$414K 0.36% 5,000
RARE icon
37
Ultragenyx Pharmaceutical
RARE
$2.89B
$393K 0.34% 8,472 -3,427 -29% -$159K
MDCO
38
DELISTED
Medicines Co
MDCO
$383K 0.33% 14,000
BIVV
39
DELISTED
Bioverativ Inc. Common Stock
BIVV
$361K 0.31% 6,689 -4,367 -39% -$236K
NBIX icon
40
Neurocrine Biosciences
NBIX
$13.8B
$326K 0.28% 4,204 -5,440 -56% -$422K
SNR
41
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$316K 0.27% 41,850
AKBA icon
42
Akebia Therapeutics
AKBA
$833M
$312K 0.27% 21,009
UTHR icon
43
United Therapeutics
UTHR
$13.8B
$303K 0.26% 2,050 -2,058 -50% -$304K
HRTX icon
44
Heron Therapeutics
HRTX
$207M
$287K 0.25% 15,874
AVXS
45
DELISTED
AveXis, Inc. Common Stock
AVXS
$277K 0.24% 2,500
GRFS icon
46
Grifois
GRFS
$6.78B
$265K 0.23% 11,565 -13,240 -53% -$303K
TECH icon
47
Bio-Techne
TECH
$8.5B
$257K 0.22% 1,987 -2,281 -53% -$295K
JUNO
48
DELISTED
Juno Therapeutics, Inc.
JUNO
$255K 0.22% 5,588 -9,132 -62% -$417K
CRL icon
49
Charles River Laboratories
CRL
$8.04B
$236K 0.2% 2,154 -2,801 -57% -$307K
IQV icon
50
IQVIA
IQV
$32.4B
$236K 0.2% 2,415 -2,998 -55% -$293K